WARBERG ASSET MANAGEMENT LLC – Inhibikase Therapeutics, Inc. Transaction History
WARBERG ASSET MANAGEMENT LLC portfolio value:
$13,000
portfolio value
WARBERG ASSET MANAGEMENT LLC quarter portfolio value change:
+22.54%
quarter
Inhibikase Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 2K | $0.91 | 14.49K | |
| Q2 2022 | share | Increase | +7.41% | 1K shares | -9K | $0.74 | 14.49K |
| Q1 2022 | share | Increase | +8.00% | 999 shares | 2K | $1.48 | 13.49K |
| Q4 2021 | share | Decrease | -51.95% | -13.50K shares | -31K | $1.5 | 12.49K |